首页> 外文期刊>Medicine studies. >C. Y. Read, R. C. Green, and M. A. Smyer (eds): Aging, Biotechnology and the Future :The Johns Hopkins University Press, Baltimore, 2008, ISBN 13: 978-0-8018-8788-8
【24h】

C. Y. Read, R. C. Green, and M. A. Smyer (eds): Aging, Biotechnology and the Future :The Johns Hopkins University Press, Baltimore, 2008, ISBN 13: 978-0-8018-8788-8

机译:C. Y. Read,R。C. Green和M. A. Smyer(eds):老龄化,生物技术与未来:约翰霍普金斯大学出版社,巴尔的摩,2008年,ISBN 13:978-0-8018-8788-8

获取原文
获取原文并翻译 | 示例
       

摘要

Aging, Biotechnology and the Future is a collection of papers concerned with the clinical dilemmas, ethical problems and social equity issues deriving from the implementation of technologies to screen, diagnose and manage age-associated illnesses. Drawing on presentations from a multidisciplinary symposium held in Boston in 2005, the volume includes contributions from biologists, psychologist, neurologists, theologists, ethicists and geriatricians. The book takes as its point of departure three questions posed by French philosopher Michel Philibert in 1979: "Of aging, what can we know? About aging, what must we hope? With aging, what can we do" (p. xii). The use of Philibert's work is significant in that it frames the ethical stance of most of the papers included here. Known for his work with the University of the Third Age in France and abroad, Philibert is also widely recognised for his pioneering work in establishing the field of 'gerontological humanities' and in particular for extending the phenomenological hermeneutics of Paul Ricouer into the analysis of aging and images of ageing. For Philibert, ageing is not only a biological process but also an 'experience [that is] interpreted and conducted or managed according to individual and collective forms of thought and action' (Philibert 1982: 13). Philibert was concerned that the biological approach to the study and management of ageing was reducing the range of available forms of thought and action, or repertoires that we have to think about such an experience. His aim, in ricouerian fashion, was to create new meaning to 'open up' new worlds of ageing.
机译:《衰老,生物技术和未来》是与临床难题,道德问题和社会公平问题相关的论文的集​​合,这些论文来自于实施筛查,诊断和管理与年龄有关的疾病的技术。本书的内容借鉴了2005年在波士顿举行的一次跨学科研讨会的演讲,其中包括生物学家,心理学家,神经病学家,神学家,伦理学家和老年学家的贡献。这本书以法国哲学家米歇尔·菲利伯特(Michel Philibert)在1979年提出的三个问题为出发点:“衰老,我们能知道什么?衰老,我们必须希望什么?衰老,我们能做什么”(第十二页)。 Philibert著作的用途很重要,因为它体现了此处包含的大多数论文的道德立场。 Philibert因在法国和国外的第三年龄大学的工作而闻名,他在建立“人类学人类学”领域,尤其是将Paul Ricouer的现象学诠释学扩展到衰老分析方面的开拓性工作也得到了广泛认可。和图像的老化。对Philibert而言,衰老不仅是一个生物过程,而且是“一种根据个人和集体的思想和行为形式来解释,进行或管理的经验”(Philibert 1982:13)。 Philibert担心,研究和管理衰老的生物学方法正在减少可用的思想和行动形式,或我们不得不考虑的这种经验的范围。他的目标是按照米国风格,创造新的意义,以“打开”新的世界。

著录项

相似文献

  • 外文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号